Non-invasive vacuum erection device improves curvature in Peyronie's disease: CUAJ

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-01-10 13:04 GMT | Update On 2021-01-10 13:04 GMT

Canada: Vacuum erection device (VED) traction therapy may improve curvature resolution in patients opting for non-invasive management of Peyronie's disease (PD), suggests a recent study in the Canadian Urological Association Journal.

Peyronie's disease, a connective tissue disorder of the penis, affects about 0.7– 11% of men. Numerous treatments have been proposed for the disorder. Options for invasive management include injectable or surgical therapy while penile traction therapy with VED is a non-invasive approach. Landan P. MacDonald from Dalhousie University in Canada and colleagues assessed outcomes for PD patients who opt for non-invasive management.

The researchers performed a retrospective analysis for 53 PD patients who were followed for at least 3 months and opted for non-invasive therapy. The patients were instructed to initiate VED traction therapy for 10 minutes twice per day. At initial and subsequent encounters, patients were assessed for the degree of PD deformity and erectile function (Sexual Health Inventory for Men [SHIM] score).

Also Read: Low sexual desire complaints by men up 32% in post-Viagra age: Study

Key findings of the study include:

Among untreated patients who did not use a VED, nine showed improvement, 20 remained stable, and four had worsening curvature.
The untreated group had a significant change in curvature, with a mean improvement (SD) of 3.6 (12) º.
All 20 men who initiated VED traction therapy had an improvement in curvature with a significant mean (SD) improvement of 23 (16) º.
Changes in SHIM scores did vary significantly between groups.
No complications were noted.

"In patients opting for non-invasive management of PD, VED traction therapy provided improved curvature resolution compared to those who do not use such a device," concluded the authors.

Also Read: Sarcopenia, new prognostic marker in penile cancer patients: Study

The study, "Outcome analysis of patients with Peyronie's disease who elect for vacuum erection device therapy," is published in the Canadian Urological Association Journal.

DOI: https://cuaj.ca/index.php/journal/article/view/6205

Article Source : Canadian Urological Association Journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Non-invasive vacuum erection device improves curvature in Peyronie's disease: CUAJ

Similar News

Why male embryos grow faster: Study reveals genetic clues

Protein deficiency during pregnancy and lactation may compromise sperm viability in offspring: Study

Urinary NGAL Emerges as a Reliable Biomarker in Nephrotic Syndrome: Study Finds

Women With Metabolic Syndrome Face Higher Odds of Overactive Bladder: Study

Dyslipidemia in CKD: Beyond Glucose Absorption in Peritoneal Dialysis, suggests study

Belatacept Safer than calcineurin inhibitors in Kidney Transplantation patients, reveals research

Both AKI Stage 1A and 1B Increase Mortality in Cirrhosis, suggests study

Study Links Ultra-Processed Foods to Metabolic and Reproductive Harm